LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | barcode | cell_count | frac_dead | corpse_count | cell_count_dead | row | column | agent | concentration | role | timepoint | replicate | cell_line | dead_count | fraction_dead | cell_count__time0 | dead_count__time0 | cell_count__ctrl | dead_count__ctrl | fraction_dead__ctrl | increase_fraction_dead | GRvalue |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trametinib | 180614_BG_02 | 1685 | 0.0366 | 35 | 28 | 4 | 17 | Trametinib | 0.099799981 | treatment | 72 | 1 | MCF10A-GM_1 | 63 | 0.0360 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01605 | 0.1619 |
Etoposide | 180703_BG_11 | 1686 | 0.1069 | 166 | 32 | 14 | 4 | Etoposide | 3.193598006 | treatment | 72 | 3 | MCF10A-GM_5 | 198 | 0.1051 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.07330 | 0.0504 |
Trametinib | 180622_BG_6 | 1686 | 0.0937 | 128 | 42 | 7 | 12 | Trametinib | 0.031603332 | treatment | 72 | 2 | MCF10A-GM_2 | 170 | 0.0916 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.06547 | 0.1664 |
Neratinib | 180622_BG_6 | 1691 | 0.0642 | 68 | 45 | 11 | 20 | Neratinib | 0.997999609 | treatment | 72 | 2 | MCF10A-GM_3 | 113 | 0.0626 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.03651 | 0.1672 |
Trametinib | 180622_BG_6 | 1705 | 0.0800 | 96 | 48 | 8 | 5 | Trametinib | 0.319359801 | treatment | 72 | 2 | MCF10A-GM_3 | 144 | 0.0779 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.05176 | 0.1693 |
Etoposide | 180703_BG_12 | 1707 | 0.0508 | 63 | 27 | 12 | 4 | Etoposide | 3.193598006 | treatment | 72 | 3 | MCF10A-GM_9 | 90 | 0.0501 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.01828 | 0.0537 |
Etoposide | 180703_BG_11 | 1710 | 0.1078 | 182 | 22 | 14 | 16 | Etoposide | 9.98 | treatment | 72 | 3 | MCF10A-GM_6 | 204 | 0.1066 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.07478 | 0.0542 |
Neratinib | 180622_BG_8 | 1714 | 0.0704 | 47 | 77 | 13 | 14 | Neratinib | 3.160329364 | treatment | 72 | 2 | MCF10A-GM_9 | 124 | 0.0675 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.04134 | 0.1706 |
Etoposide | 180703_BG_11 | 1724 | 0.0998 | 149 | 38 | 4 | 13 | Etoposide | 9.98 | treatment | 72 | 3 | MCF10A-GM_4 | 187 | 0.0979 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.06606 | 0.0563 |
Trametinib | 180622_BG_8 | 1729 | 0.0463 | 42 | 40 | 11 | 8 | Trametinib | 0.319359801 | treatment | 72 | 2 | MCF10A-GM_9 | 82 | 0.0453 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.01915 | 0.1728 |
Taxol | 180703_BG_11 | 1739 | 0.7248 | 677 | 1074 | 5 | 16 | Paclitaxel | 0.00998 | treatment | 72 | 3 | MCF10A-GM_4 | 1751 | 0.5017 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.46992 | 0.0587 |
Trametinib | 180622_BG_8 | 1740 | 0.0595 | 59 | 48 | 8 | 13 | Trametinib | 0.319359801 | treatment | 72 | 2 | MCF10A-GM_8 | 107 | 0.0579 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.03181 | 0.1744 |
Etoposide | 180622_BG_8 | 1742 | 0.0793 | 61 | 82 | 10 | 12 | Etoposide | 0.997999808 | treatment | 72 | 2 | MCF10A-GM_8 | 143 | 0.0759 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.04974 | 0.1747 |
Etoposide | 180703_BG_10 | 1749 | 0.0332 | 28 | 31 | 10 | 7 | Etoposide | 9.98 | treatment | 72 | 3 | MCF10A-GM_3 | 59 | 0.0326 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.00083 | 0.0602 |
Trametinib | 180614_BG_02 | 1751 | 0.0322 | 18 | 39 | 9 | 11 | Trametinib | 0.998 | treatment | 72 | 1 | MCF10A-GM_2 | 57 | 0.0315 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01153 | 0.1724 |
Trametinib | 180614_BG_02 | 1752 | 0.0570 | 39 | 63 | 6 | 4 | Trametinib | 0.031603332 | treatment | 72 | 1 | MCF10A-GM_1 | 102 | 0.0550 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.03502 | 0.1726 |
Vorinostat | 180703_BG_11 | 1752 | 0.1601 | 234 | 84 | 5 | 17 | Vorinostat | 9.98 | treatment | 72 | 3 | MCF10A-GM_5 | 318 | 0.1536 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.12182 | 0.0606 |
Dasatinib | 180622_BG_6 | 1758 | 0.1826 | 109 | 232 | 13 | 9 | Dasatinib | 3.193598006 | treatment | 72 | 2 | MCF10A-GM_3 | 341 | 0.1625 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.13633 | 0.1771 |
Trametinib | 180622_BG_8 | 1759 | 0.0698 | 76 | 52 | 6 | 20 | Trametinib | 0.998 | treatment | 72 | 2 | MCF10A-GM_7 | 128 | 0.0678 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.04171 | 0.1772 |
Etoposide | 180703_BG_11 | 1760 | 0.0979 | 161 | 27 | 14 | 17 | Etoposide | 3.193598006 | treatment | 72 | 3 | MCF10A-GM_6 | 188 | 0.0965 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.06471 | 0.0619 |
Neratinib | 180622_BG_8 | 1764 | 0.0705 | 67 | 62 | 4 | 22 | Neratinib | 3.160329364 | treatment | 72 | 2 | MCF10A-GM_7 | 129 | 0.0681 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.04202 | 0.1780 |
Neratinib | 180614_BG_03 | 1766 | 0.0627 | 53 | 61 | 9 | 8 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_5 | 114 | 0.0606 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.04064 | 0.1748 |
Palbociclib | 180614_BG_02 | 1772 | 0.0526 | 54 | 42 | 6 | 15 | Palbociclib | 3.160329361 | treatment | 72 | 1 | MCF10A-GM_2 | 96 | 0.0514 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.03140 | 0.1757 |
Trametinib | 180614_BG_02 | 1775 | 0.0252 | 11 | 34 | 3 | 20 | Trametinib | 0.319359801 | treatment | 72 | 1 | MCF10A-GM_1 | 45 | 0.0247 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00473 | 0.1762 |
Dasatinib | 180622_BG_6 | 1778 | 0.1612 | 65 | 232 | 12 | 3 | Dasatinib | 3.193598006 | treatment | 72 | 2 | MCF10A-GM_2 | 297 | 0.1431 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.11701 | 0.1800 |